Jess Hadley, community pharmacist and Professional Officer at PDL[/caption]
Peter Guthrey, Senior Pharmacist – Strategic Policy at PSA[/caption]
Professor Margie Danchin[/caption]
Dr Peter Tenni[/caption]
How should we deprescribe gabapentinoids, according to the Maudsley Deprescribing Guidelines[/caption]
Dapagliflozin for infertility for women with obesity
This glucose-lowering diabetes drug may have therapeutic benefits and clinical utility for people with reproductive dysfunction.
New data reveals overprescribing of antibiotics in hospitals
Almost one-quarter of prescriptions in hospitals have been assessed as inappropriate, and one-third were non-compliant with guidelines, according to new data from the Hospital...
The science of safety
All about PSA Lifetime Fellow Dr John McEwen’s evolution from pharmacy apprentice to international authority on pharmacovigilance.
Choosing Wisely – a look at prescribing cascades
In the first of a six-part series, we expand on the PSA Choosing Wisely recommendations. This month: beware the prescribing cascade.
The decision to initiate...
From the President: Include pharmacists on the Medicare Benefits Schedule
A key tenet of PSA’s strategic intent is ensuring pharmacists are rewarded and recognised to reflect our high levels of training, our expertise and...
Breast cancer awareness more important than ever
This Breast Cancer Awareness month, pharmacists should urge women to remain vigilant about screening after months of lockdown for many.
